. 2019 Apr 7;176(14):2539–2558. doi: 10.1111/bph.14633

Table 1.

Characterisation of β₃‐adrenoceptor (AR) ligands and cell lines mentioned in this article

β₃‐Adrenoceptor ligands
Ligand	Property
BRL 26,830	β₃‐AR‐selective agonist
BRL 37,344	β‐AR with poor selectivity for β₃‐AR
CGP 12,177	β₁/β₂‐adrenoceptor antagonist; partial β₃‐AR agonist; β₁/β₂‐AR radioligand, lower affinity for β₃‐AR
CL 316,243	β₃‐AR‐selective agonist
D7114	β₃‐AR‐selective agonist
Fenoterol	β₂‐AR‐selective agonist
FR 149,175	β₃‐AR‐selective agonist
Iodocyanopindolol	β₁/β₂‐AR radioligand, lower affinity for β₃‐AR
Isoprenaline	β‐AR antagonist, all subtypes
L 748,337	β₃‐AR‐selective antagonist/biased agonist; also radioligand
Mirabegron	β₃‐AR‐selective agonist
Ritobegron	β₃‐AR‐selective agonist
Ro 16‐8714	β₃‐AR‐selective agonist
Salbutamol	β₂‐AR‐selective agonist
SB 206,606	β₃‐AR radioligand
Solabegron	β₃‐AR‐selective agonist
SR 59,119	β₃‐AR‐selective agonist
SR 59,230	β‐AR antagonist, all subtypes

Note: For references on ligands, see Baker (2005, 2010) and Hoffmann, Leitz, Oberdorf‐Maass, Lohse, and Klotz (2004).